2.0750
-0.2450
(-10.56%)
At close: January 10 at 4:00:02 PM EST
2.2600
+0.19
+(8.92%)
After hours: January 10 at 7:21:09 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 5 | 8 | 8 |
| Avg. Estimate | -0.64 | -0.67 | -2.35 | -2.58 |
| Low Estimate | -0.73 | -0.74 | -2.47 | -3.25 |
| High Estimate | -0.45 | -0.46 | -2.1 | -1.56 |
| Year Ago EPS | -0.46 | -0.51 | -1.65 | -2.35 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 5 | 7 | 7 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.39 | -0.48 | -0.57 | -0.61 |
| EPS Actual | -0.46 | -0.51 | -0.56 | -0.62 |
| Difference | -0.07 | -0.03 | 0.01 | -0.01 |
| Surprise % | -17.28% | -5.42% | 2.00% | -2.17% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.64 | -0.67 | -2.35 | -2.58 |
| 7 Days Ago | -0.64 | -0.73 | -2.31 | -2.7 |
| 30 Days Ago | -0.61 | -0.73 | -2.28 | -2.68 |
| 60 Days Ago | -0.59 | -0.67 | -2.24 | -2.38 |
| 90 Days Ago | -0.6 | -0.67 | -2.25 | -2.39 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | 1 | 1 | 1 | -- |
| Down Last 30 Days | 7 | 1 | 2 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CABA | -39.29% | -32.19% | -42.32% | -9.93% |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
| Downgrade | Evercore ISI Group: Outperform to In-Line | 12/20/2024 |
| Downgrade | Wells Fargo: Overweight to Equal-Weight | 12/19/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/18/2024 |
| Maintains | Wells Fargo: Overweight to Overweight | 11/15/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/15/2024 |
| Initiated | UBS: Buy | 10/10/2024 |
Related Tickers
FDMT 4D Molecular Therapeutics, Inc.
5.52
-5.48%
KYTX Kyverna Therapeutics, Inc.
3.4500
-9.21%
STOK Stoke Therapeutics, Inc.
9.00
+0.45%
NTLA Intellia Therapeutics, Inc.
10.20
-15.14%
APLT Applied Therapeutics, Inc.
0.6791
-6.40%
IGMS IGM Biosciences, Inc.
2.0900
-66.29%
ZNTL Zentalis Pharmaceuticals, Inc.
2.7500
-1.08%
ELEV Elevation Oncology, Inc.
0.6504
-13.72%
PALI Palisade Bio, Inc.
1.9100
-4.98%
VTYX Ventyx Biosciences, Inc.
2.0800
-7.56%